Influence of gender and genetic variability on plasma angiotensin peptides

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 7, Issue 2, 2006, Pages 92-97

  Reyes Engel, Armando ^a   Morcillo, Luis ^a   Aranda, Francisco Javier ^b   Ruiz, Maximiliano ^a   Gaitan, Maria Jesús ^a   Mayor Olea, Álvaro ^a   Aranda, Pedro ^b   Ferrario, Carlos Maria ^c  

^a UNIVERSIDAD DE MÁLAGA   (Spain)

^b HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

A1166C AT1 receptor; Angiotensin II and Angiotensin (1 7) peptide levels; Human Angiotensin I; I D angiotensin converting enzyme; M235T angiotensinogen; Polymorphism

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN DERIVATIVE; ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN[1-7]; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGE DISTRIBUTION; ANGIOTENSIN BLOOD LEVEL; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC CORRELATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MEAN ARTERIAL PRESSURE; NORMAL HUMAN; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; QUANTITATIVE ANALYSIS; RADIOIMMUNOASSAY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RESTRICTION MAPPING; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSINOGEN; FEMALE; GENOTYPE; HUMANS; MALE; PEPTIDE FRAGMENTS; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RECEPTOR, ANGIOTENSIN, TYPE 1; SEX FACTORS;

EID: 33748645286     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.3317/jraas.2006.015     Document Type: Article

References (39)

1. Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992;71:7-20.
2. Bloem LJ, Foroud TM, Ambrosius WT, Hanna MP, Tewksbury DA, Pratt JH. Association of the angiotensinogen gene to serum angiotensinogen in blacks and whites. Hypertension 1996;29:1078-82.
3. Bloem LJ, Manatunga AK, Tewksbury DA, Pratt JH. The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children. J Clin Invest 1995;95:948-53.
4. Winkelmann BR, Russ AP, Nauck M et al. Angiotensinogen M235T polymorphism is associated with plasma angiotensinogen and cardiovascular disease. Am Heart J 1999;137:698-705.
5. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-6.
6. Tiret L, Rigat B, Visvikis S et al. Evidence from combined segregation and linkage analysis that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992;51:197-205.
7. Danser AH, Deinum J, Osterop AP, Admiraal PJ, Schalekamp MA. Angiotensin I to angiotensin II conversion in the human forearm and leg. Effect of the angiotensin converting enzyme gene insertion/deletion polymorphism. J Hypertens 1999;17:1867-72.
8. Spiering W, Kroon AA, Fuss-Lejeune MM, Daemen MJ, de Leeuw PW. Angiotensin II sensitivity is associated with the angiotensin II type 1 receptor A(1166)C polymorphism in essential hypertensives on a high sodium diet. Hypertension 2000;36:411-16.
9. World Health Organisation-International Society of Hypertension. Guidelines for the management of hypertension. J Hypertens 1999;17:151-83.
10. American Society of Hypertension. Recommendations for routine blood pressure measurement by indirect cuff sphygmomanometry. Am J Hypertens 1992;5:207-09.
11. Rigat B, Hubert C, Corvol P, Soubrier E. PCR detection of the insertion/ deletion polymorphism of the human angiotensin-converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase). Nucleic Acids Res 1992;20:1433.
12. Shanmugan V, Sell KW, Saha BK. Mistyping ACE heterozygotes. PCR Metbods Applications 1993;3:120-1.
13. Russ AP, Maerz W, Ruzicka V, Stein U, Grob W. Rapid detection of the hypertension associated met235-Thr allele of the human angiotensinogen gene. Hum Mol Genet 1993;2:609-10.
14. Fernandez-Arcas N, Dieguez-Lucena JL, Muñoz-Moran E et al. The genotype interactions of methylenetetrahydrofolate reductase and renin-angiotensin system genes are associated with myocardial infarction. Atherosclerosis 1999;145:293-300.
15. Iyer SN, Ferrario CM, Chappell MC. Angiotensin-(1-7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system. Hypertension 1998;31:356-61.
16. Shimamoto K, Nakagawa M, Iimura O. In vivo concentration of kinins and angiotensins. Horm Metab Res Suppl 1990;22:75-9.
17. Matsui T, Tamaya K, Maysumoto K, Osajima Y, Uezono K, Kawasaki T. Plasma concentration of angiotensin metabolites in young male normotensive and mild hypertensive subjects. Hypertens Res 1999;22:273-7.
18. Gandhi SK, Gainer J, King D, Brown NJ. Gender affects renal vasoconstrictor response to Ang I and Ang II. Hypertension 1998;31:90-6.
19. Jalil JE, Palomera C, Ocaranza MP, Godoy I, Roman M, Chiong M, Lavandero S. Levels of plasma angiotensin-(1-7) in patients with hypertension who have the angiotensin-I-converting enzyme deletion/deletion genotype. Am J Cardiol 2003;92(6):749-51.
20. Sethi AA, Nordestgaard BG, Gronholdt ML, Steffensen R, Jensen G, Tybjaerg-Hansen A. Angiotensinogen single nucleotide polymorphisms, elevated blood pressure, and risk of cardiovascular disease. Hypertension 2003;41:1202-11.
21. Chappell MC, Pirro NT, Sykes A, Ferrario CM. Metabolism of angiotensin-(1-7) by angiotensin converting enzyme. Hypertension 1998;31:362-7.
22. Yamada K, Shridhar NI, Chappell MC, Ganten D, Ferrario CM. Converting enzyme determines plasma clearance of angiotensin-(1-7). Hypertension 1998;32:496-502.
23. Danser AH, Derkx FH, Schalekamp MA, Hense HW, Riegger GA, Schunkert H. Determinants of interindividual variation of renin and prorrenin concentrations: evidence for a sexual dimorphism of (pro)renin levels in humans. J Hypertens 1998;16:853-62.
24. Ferrario CM. Angiotensin-(1-7) and antihypertensive mechanisms. J Nephrol 1998;11:278-83.
25. Li P, Chappell MC, Ferrario CM, Brosnihan KB. Angiotensin-(1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide. Hypertension 1997;29:394-400.
26. Paula RD, Lima CV, Britto RR, Campagnole-Santos MJ, Khosla MC, Santos RA. Potentiation of the hypotensive effect of bradykinin by angiotensin-(1-7)-related peptides. Peptides 1999;20:493-500.
27. Campbell DJ. Differential regulation of angiotensin peptides in plasma and kidney: effects of adrenalectomy and estrogen treatment. Clin Exp Hypertens 1997; 19:687-98.
28. Danser AH, Derkx FH, Hense HW, Jeunemaitre X, Riegger GA, Schunkert H. Angiotensinogen (M235T) and angiotensin-converting enzyme (I/D) polymorphisms in association with plasma renin and prorenin levels. J Hypertens 1998;16:1879-83.
29. Morgan L, Crawshaw S, Baker PN, Pipkin FB, Kalsheker N. Polymorphism in oestrogen response element associated with variation in plasma angiotensinogen concentrations in healthy pregnant women. J Hypertens 2000;18:553-7.
30. Pratt JH, Ambrosius WT, Tewksbury DA, Wagner MA, Zhou L, Hanna MR. Serum angiotensinogen concentration in relation to gonadal hormones, body size, and genotype in growing young people. Hypertension 1998;32:875-9.
31. Gallagher PE, Li P, Lenhart JR, Chappell MC, Brosnihan KB. Estrogen regulation of angiotensin-converting enzyme mRNA. Hypertension 1999;31:323-8.
32. Chappell MC, Diz DI, Yunis C, Ferrario CM. Differential actions of angiotensin-(1-7) in the kidney. Kidney Int Suppl 1998;68:S3-S6.
33. Paillard F, Chansel D, Brand E et al. Genotype-phenotype relationships for the renin-angiotensin-aldosterone system in a normal population. Hypertension 1999;34:423-9.
34. Roks AJ, van Geel PP, Pinto YM et al. Angiotensin-(1-7) is a modulator of the human renin-angiotensin system. Hypertension 1999;34:296-301.
35. Saris JJ, Van Dijk MA, Kroon I, Schalekamp MA, Danser AH. Functional importance of angiotensin-converting enzyme-dependent in situ angiotensin II generation in the human forearm. Hypertension 2000;35:764-8.
36. Ferrario CM, Barnes KL, Block CH et al. Pathways of angiotensin formation and function in the brain. Hypertension 1990;15:113-19.
37. Crackower MA, Sarao R, Oudit GY et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 2002;417:822-8.
38. Fernandez-Arcas N, Dieguez-Lucena JL, Munoz-Moran E et al. Both alleles of the M235T polymorphism of the angiotensinogen gene can be a risk factor for myocardial infarction. Clin Genet 2001;60(1):52-7.
39. Kruse HJ, Wieczorek I, Hecker H, Creutzig A, Schellong SM. Seasonal variation of endothelin-1, angiotensin II, and plasma catecholamines and their relation to outside temperature. J Lab Clin Med 2002;140:236-41.